通过芯片上的血栓炎症进行临床相关的血栓分离
在PubMed上查看摘要
概括
此摘要是机器生成的。一个新的芯片模型揭示了微血管血栓炎症如何消失,确定了中性粒细胞弹性酶作为关键因素,并指导了凝块消失和疾病治疗的治疗策略.
科学领域
- 生物医学工程
- 心血管研究
- 翻译医学
背景情况
- 在各种疾病中,血栓炎引起微血管封闭和末端器官衰竭.
- 了解微血管血栓炎症的解决方案受到规模和持续时间的限制.
- 现有的模型无法充分捕捉血栓的长期动态.
研究的目的
- 开发一种新的体外模型来研究微血管血栓炎症的解决方案.
- 阐明微血管血栓炎的时间阶段和凝块分离机制.
- 研究预防血栓形成和促进血栓解脱的治疗策略.
主要方法
- 开发基于水凝的长期培养能力的芯片上的血栓炎症模型.
- 使用多重RNA光在现场混合来分析细胞和分子变化.
- 在临床上相关的时间范围内 (多达几个月) 监测血栓分离.
主要成果
- 在微血管血栓炎症中绘制出血栓分离的不同时间阶段.
- 已经证明炎症会使内皮纤维溶解平衡转向血栓形成.
- 确定中性粒细胞弹性酶是促进分离和组织损伤的双重作用因子.
- 早期组织等离子素激活剂改善内皮屏障功能.
- 通过内皮介导途径抑制血栓炎症.
- 在状细胞疾病中,联合沙和克里桑利祖马布可减少微血管封闭并保护内皮.
结论
- 开发的芯片模型可以长期研究微血管血栓炎症的解决方案.
- 中性粒细胞弹性酶在凝块分解和潜在的组织损伤中发挥着关键作用.
- 治疗干预措施可以评估它们在预防血栓形成和促进溶解方面的有效性.
- 这种平台有助于发现治疗血栓炎症疾病的药物,包括状细胞疾病.
相关概念视频
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

